BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 11, 2019
View Archived Issues
Mosquito diet drugs could block spread of multiple diseases
Read More
Gene therapy found effective in a mouse model of Fabry disease
Read More
Antidepressant also fights sepsis
Read More
Chronic inflammation leads to 'immunological scarring'
Read More
Orally active GPR119 agonist demonstrates hypoglycemic effects in rats
Read More
Discovery and preclinical characterization of novel pan-PIM kinase inhibitor
Read More
Ganglioside analogue modulates APP processing and function rescuing neurodegeneration in AD
Read More
Multifunctional carbazole-based dopamine agonists for the treatment of Parkinson's disease
Read More
Phase III data presented for pegunigalsidase alfa in the treatment of Fabry disease
Read More
uniQure presents updated data from phase IIb study of AMT-061 in hemophilia B
Read More
China's NMPA accepts IND filing for combination of CS-1001 and IMP-4297 for solid tumors
Read More
First patient treated in phase Ib/II study of ilixadencel with checkpoint inhibitors
Read More
Data from phase Ib/II trial of NVX-208 in acute ischemic stroke warrant further investigation
Read More
Phoenix Tissue Repair studies PTR-01 in patients with recessive dystrophic epidermolysis bullosa
Read More
New SUMO-1 activators discovered at the Icahn School of Medicine
Read More
Washington University and Saint Louis University patent antitubercular compounds
Read More
Jiangsu Aosaikang Pharmaceutical and collaborators patent EGFR inhibitors
Read More
Metallo-beta-lactamase inhibitors identified at Merck & Co.
Read More
New adenosine receptor antagonists disclosed by Girafpharma
Read More
Fortis initiates phase I study of FOR-46 in metastatic CRPC
Read More
Follicum selects drug candidate for diabetes and protection of beta cells
Read More
Lilly begins phase I study of LY-3405105 in advanced solid tumors
Read More
Alpine initiates first-in-human trial of dual ICOS/CD28 antagonist ALPN-101
Read More